These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2586012)

  • 21. The effects of ticrynafen in the rat.
    Minor S; Taylor K; Knight TF; Senekjian HO; Weinman EJ
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):53-63. PubMed ID: 451359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects.
    Shen Z; Gillen M; Miner JN; Bucci G; Wilson DM; Hall JW
    Drug Des Devel Ther; 2017; 11():2077-2086. PubMed ID: 28744099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of benzbromarone and its combination with hydrochlorothiazide on renal excretion of uric acid and electrolytes.
    Malý J; Schück O
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):443-5. PubMed ID: 2258255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uricosuric effect of benziodarone in man and laboratory animals: a comparative study.
    Lemieux G; Gougoux A; Vinay P; Michaud G
    Am J Physiol; 1973 Jun; 224(6):1431-9. PubMed ID: 4197184
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypouricemia due to renal urate wasting. Two types of tubular transport defect.
    Tofuku Y; Kuroda M; Takeda R
    Nephron; 1982; 30(1):39-44. PubMed ID: 7088231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].
    Zöllner N; Dofel W; Gröbner W
    Klin Wochenschr; 1970 Apr; 48(7):426-32. PubMed ID: 5521255
    [No Abstract]   [Full Text] [Related]  

  • 28. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the decrease of uric acid level in the plasma with benzbromarone].
    Zöllner N; Stern G; Gröbner W; Dofel W
    Klin Wochenschr; 1968 Dec; 46(24):1318-9. PubMed ID: 5714791
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of diltiazem on plasma uric acid level and renal uric acid excretion in rats.
    Sugino H; Shimada H
    Jpn J Pharmacol; 1989 Jun; 50(2):239-42. PubMed ID: 2770059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase inhibitory and uricosuric activities of FK366 in healthy volunteers.
    Kanamaru M; Uematsu T; Nagashima S; Mizuno A; Terakawa M; Sugiyama A; Nakashima M
    J Clin Pharmacol; 1993 Nov; 33(11):1122-31. PubMed ID: 8300896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal transport of urate during diuretic-induced hypouricemia.
    Reese OG; Steele TH
    Am J Med; 1976 Jun; 60(7):973-9. PubMed ID: 937359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
    Mertz DP; Eichhorn R
    Klin Wochenschr; 1984 Dec; 62(24):1170-2. PubMed ID: 6530890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biorhythm in the renal excretion of electrolytes and uric acid in healthy subjects.
    Grigoleit HG; Sörgel F
    S Afr Med J; 1980 Dec; 58(23):933-6. PubMed ID: 7444690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species variations among primates in responses to drugs which alter the renal excretion of uric acid.
    Fannelli GM; Weiner IM
    J Pharmacol Exp Ther; 1975 May; 193(2):363-75. PubMed ID: 806677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
    Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
    Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urate excretion: drug interactions.
    Fanelli GM; Weiner IM
    J Pharmacol Exp Ther; 1979 Aug; 210(2):186-95. PubMed ID: 110920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent uricosuric effect of ambroxol.
    Oosterhuis B; Storm G; Cornelissen PJ; Su CA; Sollie FA; Jonkman JH
    Eur J Clin Pharmacol; 1993; 44(3):237-41. PubMed ID: 8491237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic/pharmacodynamic modeling and simulation of dotinurad, a novel uricosuric agent, in healthy volunteers.
    Motoki K; Igarashi T; Omura K; Nakatani H; Iwanaga T; Tamai I; Ohashi T
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00533. PubMed ID: 31788318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
    Gresser U; Gathof BS; Gross M
    Adv Exp Med Biol; 1994; 370():87-90. PubMed ID: 7661033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.